Palladin, Cytoskeletal Associated Protein (PALLD) (N-Term) Peptide
PALLD
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5513514
Aperçu rapide pour Palladin, Cytoskeletal Associated Protein (PALLD) (N-Term) Peptide (ABIN5513514)
Antigène
PALLD
(Palladin, Cytoskeletal Associated Protein (PALLD))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Séquence
- HQRKGGPQSQ LCDKAANLIE ELTSIFKAAK PRNRSPNGES SSPDSGYLSP
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PALLD Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
-
Sujet
-
This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.
Alias Symbols: PALLD,KIAA0992,CGI-151,
Protein Size: 1383 -
ID gène
- 23022
-
NCBI Accession
- XP_005262919
-
UniProt
- Q8WX93
Antigène
-
Vous êtes ici:
